VieScope in Patients With an Expected Difficult Airway

Sponsor
Universitätsklinikum Hamburg-Eppendorf (Other)
Overall Status
Completed
CT.gov ID
NCT05044416
Collaborator
(none)
58
1
2
9.5
6.1

Study Details

Study Description

Brief Summary

Patients requiring endotracheal intubation for elective surgery with an expected difficult airway are randomized to be intubated either by a) VieScope or b) videolaryngoscopy.

Condition or Disease Intervention/Treatment Phase
  • Device: VieScope
  • Device: Videolaryngoscopy
N/A

Detailed Description

Tracheal intubation is required for different surgical procedures for mechanical ventilation and to prevent aspiration of secretions. In patients with an expected difficult airway, tracheal intubation is often performed by videolaryngoscopy (VL). However, this technique has limitations and may fail due to insufficient visualization of the larynx. A new device has been introduced that consists of an illuminated straight plastic tube for laryngoscopy (VSC, Vie Scope, Adroit Surgical, Oklahoma City, OK, USA) that enables for indirect intubation over a stylet.

So far, the VSC has shown promising results in manikin studies for intubation in normal and difficult airways. We aim to test the VSC in patients compared to videolaryngoscopy in a prospective randomized non-inferiority trial.

Patients will be assessed for eligibility in the Anesthesiology Pre-assessment Clinic of the University Medical Center Hamburg-Eppendorf prior to elective surgery. All patients receive a structured preoperative airway assessment.

Patients are randomized 1:1 to either intervention or control group. Patients randomized to the intervention group will be intubated with the VSC. Patients randomized to the control group are intubated with a MacIntosh type videolaryngoscope (CMAC, Storz, Germany).

Study Design

Study Type:
Interventional
Actual Enrollment :
58 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
randomized 1:1randomized 1:1
Masking:
Single (Participant)
Masking Description:
device for intubation may not be blinded for provider or investigator
Primary Purpose:
Treatment
Official Title:
Tracheal Intubation With VieScope Versus Videolaryngoscopy in Patients for Elective Surgery With an Expected Difficult Airway - a Prospective Randomized Trial (VieScOP-II)
Actual Study Start Date :
Sep 11, 2021
Actual Primary Completion Date :
Jun 26, 2022
Actual Study Completion Date :
Jun 26, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: VieScope

intubation with the VieScope laryngoscope

Device: VieScope
intubation with VieScope laryngoscope

Active Comparator: Videolaryngoscopy

intubation with videolaryngoscope

Device: Videolaryngoscopy
intubation with videolaryngoscope

Outcome Measures

Primary Outcome Measures

  1. Percentage of Glottis Opening (POGO) scale [15 min]

    intubating conditions according to the percentage of glottis opening scale (POGO), range 0-100%, higher values better

Secondary Outcome Measures

  1. first attempt success rate [15 min]

    percentage of successful intubations with one attempt

  2. time to intubation [15 min]

    time until tracheal airway access is established

  3. Cormack-Lehane [15 min]

    intubating conditions according to Cormack-Lehane

  4. overall success rate [15 min]

    percentage of successful intubations with the allocated procedure

  5. time to successful intubation with one attempt [15 min]

    time until tracheal airway access is established in patients that are intubated at first attempt

  6. intubation difficulty [15 min]

    subjective rating on a visual analogue scale (0-100, higher values indicate more difficult intubation) of the difficulty of airway management and questionnaire

  7. number of attempts [15 min]

    total number of attempts until airway established

  8. aspiration [15 min]

    percentage of patients that vomit and aspirate during intubation

  9. esophageal intubation [15 min]

    percentage of accidental esophageal intubation attempts

  10. hypoxia [15 min]

    percentage of patients with a desaturation below a pulsoximetric saturation of 80%

  11. hypotension [15 min]

    percentage of patients with a systolic blood pressure below 70 mmHg

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients requiring general anesthesia with transoral tracheal intubation for elective surgery

  • Age ≥ 18

  • Preoperative airway assessment reveals an expected difficult airway (rated by the responsible anesthetist in the Pre-assessment Clinic based on the existing in-house algorithm)

Exclusion Criteria:
  • Pregnant or breastfeeding woman

  • Confirmed indications for awake fiberoptic intubation especially due to enoral, pharyngeal tumors, abscesses or other processes

  • Planned endotracheal intubation without deep anesthesia or neuromuscular blocking agents (e.g. awake videolaryngoscopy)

  • Required transnasal tracheal intubation (e.g. for surgical reasons)

  • Requirement of special endotracheal tubes such as laser or RAE tubes for surgical reasons

  • Patients at risk for pulmonary aspiration who qualify for rapid sequence induction

  • Loose teeth

  • Denial of consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitätsklinikum Hamburg-Eppendorf Hamburg HH Germany 20246

Sponsors and Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

Investigators

  • Study Chair: Joern Grensemann, MD, Universitätsklinikum Hamburg-Eppendorf
  • Study Chair: Martin Petzoldt, MD, Universitätsklinikum Hamburg-Eppendorf

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universitätsklinikum Hamburg-Eppendorf
ClinicalTrials.gov Identifier:
NCT05044416
Other Study ID Numbers:
  • VieScOP-II
First Posted:
Sep 14, 2021
Last Update Posted:
Jul 1, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jul 1, 2022